AI Cardiac Ultrasound Tool Gets FDA Clearance

UltraSight software lets staff without sonography training capture heart scans, using AI to guide probe placement.

Updated on Nov. 3, 2026 in Heart Disease

AI Cardiac Ultrasound Tool Gets FDA Clearance

Live Poll

Would you trust a heart scan performed by staff without ultrasound training?

The FDA has cleared UltraSight AI cardiac ultrasound software, developed by an Israeli company, for use with adult heart scans. The software guides medical staff without prior ultrasound experience through capturing standard views of the heart.

Why it matters

The software aims to close a gap between the number of heart disease patients needing regular monitoring and the availability of trained cardiac sonographers. Its founders cited that imbalance as a key reason for building the product.

The company's study reported that medical staff without prior ultrasound experience could acquire quality images, with the software acquiring 10 standard heart views. U.S. figures cited include more than 8 million emergency room visits for possible heart attack or failure and about 30 million heart disease patients undergoing regular monitoring, while the study's sample size and detailed outcomes were not reported.

The players

UltraSight

An Israeli company that develops AI-guided cardiac ultrasound software designed to let non-sonographers capture diagnostic heart scans.

Philips Lumify Ultrasound System

A portable ultrasound platform from Philips with which UltraSight is designed to work as an accessory tool for point-of-care imaging.

The details

UltraSight works as an accessory to the Philips Lumify Ultrasound System, using an AI neural network that predicts the probe's position relative to the heart from the ultrasound video stream. It gives real-time guidance on how to manipulate the probe to capture diagnostic-quality adult transthoracic echocardiography scans. The software has also received CE marking in the EU and UKCA marking in the U.K.

• November 3, 2026: Report published on FDA clearance of UltraSight software

Big Picture

UltraSight extends the point-of-care ultrasound category exemplified by the Philips Lumify system, adding AI guidance so that the hardware can be operated by staff without sonography training. It positions AI-assisted imaging as a way to ease the shortage of trained cardiac sonographers relative to the growing number of heart disease patients.

The tool may make routine heart monitoring more accessible to patients in communities with limited access to trained cardiac sonographers. Readers should consult their clinicians about whether ultrasound monitoring is appropriate for their care.

The takeaway

AI-guided tools may broaden access to cardiac imaging by shifting some scanning tasks to staff without specialized training. Patients should discuss monitoring options with their care teams.